Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis (Q87798623)
Jump to navigation
Jump to search
scientific article published on 30 April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis |
scientific article published on 30 April 2014 |
Statements
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis (English)
Luca Prosperini
Floriana De Angelis
Rosanna De Angelis
Fulvia Fanelli